Faculty profile

Ayodele Odutayo

ResearcherMedicine/NephrologyUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses may be missing. Find their university profile.

Ayodele Odutayo

Researcher

Medicine/Nephrology

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
29 publications in the last five years, latest in 2026.
Senior (last) author on 3 recent papers, a sign of leading a research group.
Principal investigator on 5 research grants (5 CIHR), most recently in 2026.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

304

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Chronic Kidney Disease Cardiovascular Disease Sodium Glucose Co-Transporter 2 Inhibitors Aortic Stenosis Atherosclerosis Chronic Disease Health Equity Kidney Function

Latest papers

Association of Ertugliflozin on Kidney Outcomes in People After and Without an Interval Cardiovascular Event: Observations From the VERTIS CV Trial.
American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026 · first author
Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.
Canadian journal of kidney health and disease · 2026
Combination treatment for the management of chronic kidney disease and type 2 diabetes: a review and practical guidance.
The Journal of clinical endocrinology and metabolism · 2026 · senior author

All 67 publications

Latest funding

Evaluating the Safety and Acceptability of a Liberalized Potassium Diet in Maintenance Hemodialysis Recipients: A Randomized Controlled Trial (LIBERATE K-HD)
CIHR · 2026 · Co-investigator
$508,725
Lipoprotein(a) utilization, ancestry, and adverse cardiovascular and renal outcomes: a population-based cohort study
CIHR · 2026 · Principal investigator
$550,800
Adding AcetazolamIde on top of SGLT2 inhibition in Type 2 Diabetes and Albuminuria ('DIPPER') Study
CIHR · 2026 · Principal investigator
$761,176

All 9 grants and awards

67 publications.

Association of Ertugliflozin on Kidney Outcomes in People After and Without an Interval Cardiovascular Event: Observations From the VERTIS CV Trial.

Odutayo A, Cosentino F, Pratley RE, Cannon CP, Liu CC, Frederich R, Masiukiewicz U, Cater NB, Gantz I, Cherney DZI, VERTIS CV Investigators

American journal of kidney diseases : the official journal of the National Kidney Foundation2026First author

DOI: 10.1053/j.ajkd.2026.01.017 PMID: 42025783

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Sheffield M, Phelan E, Ratajczak N, Battistella M, Tennankore K, Odutayo A, Soroka S, Poyah P, More K, Naylor H, Kennie-Kaulbach N, Rainkie D, Wilson JA

Canadian journal of kidney health and disease2026

DOI: 10.1177/20543581261476643 PMID: 42602345

Combination treatment for the management of chronic kidney disease and type 2 diabetes: a review and practical guidance.

Mohsen M, Yi TW, Faruque L, Ke C, Cafazzo JA, Pham Q, Sridhar VS, Levin A, Abdel-Qadir H, Persson F, Wanner C, Jüni P, Butler J, Marx N, Cherney DZI, Odutayo A

The Journal of clinical endocrinology and metabolism2026Senior author

DOI: 10.1210/clinem/dgag163 PMID: 41973867

Association Between the 2022 AHA/ACC/HFSA Heart Failure Staging and Cardiovascular and Kidney Outcomes in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the SCORED Randomized Controlled Trial.

Odutayo A, Bhatt DL, Sridhar VS, Szarek M, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Lopes RD, Scirica BM, Ray KK, Davies MJ, Banks P, Girard M, Verma S, Udell JA, Pitt B, Steg PG, Cherney DZI

Circulation. Heart failure2026First author

DOI: 10.1161/circheartfailure.125.013054 PMID: 41569429

Advancing Understanding of Cardiovascular Risk in CKD.

Sridhar VS, Odutayo A

Journal of the American Society of Nephrology : JASN2025Senior author

DOI: 10.1681/asn.0000000606 PMID: 39899677

Authors' Reply: Further Considerations on the Clinical Evaluation of Sotagliflozin in Type 1 Diabetes with CKD.

Sridhar VS, Odutayo A, Davies MJ, Cherney DZI

Journal of the American Society of Nephrology : JASN2025

DOI: 10.1681/asn.0000000868 PMID: 41071616

Association of Albuminuria With 1-Year Risk of Heart Failure and Other Adverse Outcomes in Atrial Fibrillation.

Odutayo A, Serrano A, Chauhan A, Fang J, Sud M, Han L, Austin PC, Dorian P, Jackevicius CA, Lee DS, Singh SM, Tu K, Ko DT, Abdel-Qadir H

Journal of the American Heart Association2025First author

DOI: 10.1161/jaha.125.041185 PMID: 40878997

Biomarkers for cardiovascular-kidney metabolic syndrome: Clinical utility in diagnosis, screening, and treatment.

Yau K, Cherney DZI, Odutayo A

Diabetes, obesity & metabolism2025Senior author

DOI: 10.1111/dom.70044 PMID: 40859453

Cholesterol Levels and Cardiovascular Outcomes Following Statin Initiation for Primary Prevention: A Cohort Study.

Thompson W, Jeong I, Basque S, Abdel-Qadir H, Austin PC, Ko DT, Famiyeh I, Chu A, Fang J, Odutayo A, Jackevicius CA, Godoy LC, Lee DS, Anderson TJ, Udell JA

JACC. Advances2025

DOI: 10.1016/j.jacadv.2025.101864 PMID: 40713148

Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes and CKD.

Sridhar VS, Odutayo A, Garg S, Danne T, Doria A, Mauer M, Davies MJ, Banks P, Girard M, Cherney DZI

Journal of the American Society of Nephrology : JASN2025

DOI: 10.1681/asn.0000000540 PMID: 39485484

Something wrong or missing on this profile? Suggest a correction

Ayodele Odutayo

Research

Latest papers

Latest funding

Association of Ertugliflozin on Kidney Outcomes in People After and Without an Interval Cardiovascular Event: Observations From the VERTIS CV Trial.

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Combination treatment for the management of chronic kidney disease and type 2 diabetes: a review and practical guidance.

Association Between the 2022 AHA/ACC/HFSA Heart Failure Staging and Cardiovascular and Kidney Outcomes in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the SCORED Randomized Controlled Trial.

Advancing Understanding of Cardiovascular Risk in CKD.

Authors' Reply: Further Considerations on the Clinical Evaluation of Sotagliflozin in Type 1 Diabetes with CKD.

Association of Albuminuria With 1-Year Risk of Heart Failure and Other Adverse Outcomes in Atrial Fibrillation.

Biomarkers for cardiovascular-kidney metabolic syndrome: Clinical utility in diagnosis, screening, and treatment.

Cholesterol Levels and Cardiovascular Outcomes Following Statin Initiation for Primary Prevention: A Cohort Study.

Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes and CKD.

Frequent collaborators

Arnav Agarwal

Dominik Mertz

Jason Walter Busse

Kevin Yau

Karthik Tennankore

Rahim Moineddin

Michelle Hladunewich

David Cherney

Michael Colacci

David Moher

Jacqueline Khet-Ling Wong

Pooja Gandhi

An-Wen Chan

Subodh Verma

Michael Fralick

Adeera Levin

Ron Wald

Cal Robinson

Maneesh Sud

Marisa Battistella

Stephen Lapinsky

Sascha Drewlo

Paul Dorian

Satya Dash

Ziv Harel

Peter Gill

Quynh Pham